MSF Capital’s MSG Knickerbockers Corp. MSGK Stock Holding History

MSF Capital’s Portfolio MSGK Stock Details MSGK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,612	Closed	-$443K	–	35
2015 Q3	$443K	Hold	8,612	–	–	0.11%	38
2015 Q2	$513K	Hold	8,612	–	–	0.12%	37
2015 Q1	$520K	Buy	+8,612	New	+$473K	0.13%	35

Other funds holding MSGK

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Tran Capital Management San Rafael, California $873M AUM 51.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSF Capital's MSGK Position: Q4 2015 in Review

MSF Capital sold out of MSG Knickerbockers Corp. (MSGK) in Q4 2015, closing a stake of 8,612 shares — an estimated $443K sold.

MSF Capital first reported a position in MSGK in Q1 2015 and held it in 3 quarters. The position peaked at $520K in Q1 2015. 217 funds tracked by Wall St. Rank hold MSGK as of Q4 2015.

MSF Capital reported no remaining MSG Knickerbockers Corp. position as of Q4 2015 after selling out during the quarter.
MSF Capital sold 8,612 MSG Knickerbockers Corp. shares in Q4 2015, an estimated $443K.
MSF Capital first reported a position in MSG Knickerbockers Corp. in Q1 2015 and held it in 3 quarters.
MSF Capital's MSG Knickerbockers Corp. position peaked at $520K in Q1 2015.
217 funds tracked by Wall St. Rank held MSG Knickerbockers Corp. as of Q4 2015.

Based on MSF Capital's 13F filing for Q4 2015, filed 11 Feb 2016.